Search Results - "Lé, Ana Maria"
-
1
OX40-OX40L Inhibition for the Treatment of Atopic Dermatitis-Focus on Rocatinlimab and Amlitelimab
Published in Pharmaceutics (01-12-2022)“…Despite the recent emergence of targeted therapeutic options, there are still unmet needs concerning moderate-to-severe atopic dermatitis treatment. This…”
Get full text
Journal Article -
2
Deucravacitinib in the treatment of psoriasis
Published in The Journal of dermatological treatment (31-12-2023)“…Psoriasis is a chronic, immune-mediated, skin disease with a significantly negative impact on patients' quality of life. Moderate-to-severe disease often…”
Get full text
Journal Article -
3
Deucravacitinib for the treatment of psoriatic arthritis: the evidence so far
Published in Drugs in Context (2023)“…Psoriatic arthritis (PsA) is a heterogeneous disease that may develop in up to 30% of patients with psoriasis. PsA mainly involves peripheral joints; however,…”
Get full text
Journal Article -
4
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study
Published in American journal of clinical dermatology (01-03-2024)“…Background Tuberculosis has a major global impact. Immunocompetent hosts usually control this disease, resulting in an asymptomatic latent tuberculosis…”
Get full text
Journal Article -
5
Deucravacitinib for the Treatment of Psoriatic Disease
Published in American journal of clinical dermatology (01-11-2022)“…Psoriasis is an immune-mediated disease, with the interleukin (IL)-23/IL-17 axis currently considered its main pathogenic pathway. Tyrosine kinase 2 (TYK2) is…”
Get full text
Journal Article -
6
New Topical Therapies for Psoriasis
Published in American journal of clinical dermatology (2022)“…Psoriasis is a chronic immune-mediated skin disease with a significant impact on patients’ quality of life. Mild-to-moderate forms of the disease usually…”
Get full text
Journal Article -
7
Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors
Published in The Journal of dermatological treatment (03-10-2022)“…Generalized pustular psoriasis (GPP) is a rare yet severe variant of psoriasis, characterized by the eruption of superficial sterile pustules that appear…”
Get full text
Journal Article -
8
Subcutaneous panniculitis-like T-cell lymphoma: a case report
Published in EJD. European journal of dermatology (01-12-2023)Get full text
Journal Article -
9
Vismodegib treatment for recurrent basal cell carcinoma – a successful case report
Published in EJD. European journal of dermatology (01-06-2023)Get full text
Journal Article -
10
Rare cutaneous amyloid lesions as multiple myeloma presenting symptom
Published in International journal of dermatology (01-02-2024)Get full text
Journal Article -
11
Mogamulizumab for Sézary syndrome: long-term remission with associated autoimmune haemolytic anaemia
Published in EJD. European journal of dermatology (01-08-2024)Get full text
Journal Article -
12
Oral roflumilast in a patient with psoriasis and prostate cancer
Published in EJD. European journal of dermatology (01-10-2024)Get full text
Journal Article -
13
Journal Club: Update on pyoderma gangrenosum
Published in EJD. European journal of dermatology (01-10-2023)Get full text
Journal Article -
14
CORRECTION
Published in American journal of clinical dermatology (01-01-2022)Get full text
Journal Article -
15
Correction to: New Topical Therapies for Psoriasis
Published in American journal of clinical dermatology (2022)Get full text
Journal Article -
16
Journal club: Recent therapeutic developments in the management of chronic spontaneous urticaria
Published in EJD. European journal of dermatology (01-06-2023)Get full text
Journal Article -
17
Journal Club: Recent therapeutic developments in epidermolysis bullosa
Published in EJD. European journal of dermatology (01-04-2024)Get full text
Journal Article -
18
Journal Club: Mycosis fungoides and Sézary syndrome: an update on a classic disease
Published in EJD. European journal of dermatology (01-12-2023)Get full text
Journal Article -
19
Abrocitinib for the treatment of atopic dermatitis
Published in Immunotherapy (01-11-2023)“…Abrocitinib is an oral small molecule which selectively inhibits JAK1, modulating multiple cytokine pathways involved in atopic dermatitis. Both abrocitinib…”
Get full text
Journal Article -
20
The Impact of a Vegetarian Diet in Cardiovascular Risk
Published 01-01-2019“…Introduction:Cardiovascular disease is a leading cause of death and chronic disability, and optimizing its prevention and management remains a priority. A…”
Get full text
Dissertation